Skip to main content

Transient Gene Expression and MACS Enrichment

  • Protocol
Epstein-Barr Virus Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 174))

Abstract

The analysis of the effects of expression of one viral protein on the host cell separately from the effect of other viral proteins is often limited by the efficiency of the transfection method. Lymphoid cells are effectively transfected by electroporation (14). However, the transfection efficiency varies usually between 5 and 20% of the living cells, depending on the cell line used. In the case of primary lymphoid cells, the transfection efficiency is below 5% (57). Thus the analysis of the influence of viral genes on the expression of cellular proteins is often impossible because of the predominance of untransfected cells. In addition, some viral genes could result in cytostasis, such as latent membrance protein 1 (LMP1; 8). The establishment of cell lines, where the viral gene is expressed constitutively or in an inducible fashion, is one way to try to address the problem, but is associated with a selection process (8,9). This selection process prevents the analysis of early effects of expressed viral genes and could also lead to secondary cell culture effects not associated with the viral gene. Often, inducible gene expression systems are difficult to modulate and can be leaky. To overcome these problems, it is useful to analyze transiently transfected cells and enrich them to obtain pure cell populations without a selection process. A number of methods exist, with magnetic- or fluorescence-activated cell sorting (MACS/FACS) being the most common approaches used (10). FACS and MACS are powerful and sophisticated methods for efficient purification of cells expressing a specific immunological marker molecule. Since the introduction of the green fluorescence protein (GFP) the purification of cells by FACS is no longer limited to immunological-stained proteins, which thus opens new applications for this approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhdanov, R. I., Kutsenko, N. G., and Fedchenko, V. I. (1997) Non-viral gene transfer in gene therapy. Vopr. Med. Khim. 43, 3–12.

    PubMed  CAS  Google Scholar 

  2. Andreason, G. L. (1993) Electroporation as a technique for the transfer of macromolecules into mammalian cell lines. J. Tissue Culture Methods 15, 56–62.

    Article  Google Scholar 

  3. Fouillard, L. (1996) Physical method for gene transfer: An alternative to viruses. Hematol. Cell. Ther. 38, 214–216.

    Article  PubMed  CAS  Google Scholar 

  4. Lurquin, P. F. (1997) Gene transfer by electroporation. Mol. Biotechnol. 7, 5–35.

    Article  PubMed  CAS  Google Scholar 

  5. Peng, M. and Lundgren, E. (1995) Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7, 1775–1782.

    Google Scholar 

  6. Pilon, M., Gullberg, M., and Lundgren, E. (1991) Transient expression of the CD2 cell surface antigen as a sortable marker to monitor high frequency transfection of human primary B cells. J. Immunol. 146, 1047–1051.

    PubMed  CAS  Google Scholar 

  7. Liljeholm, S., Hughes, K., Grundström, T., and Brodin, P. (1998) NF-κB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. J. Gen. Virol. 79, 2117–2125.

    PubMed  CAS  Google Scholar 

  8. Floettmann, J. E., Ward, K., Rickinson, A. B., and Rowe, M. (1996) Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223, 29–40.

    Article  PubMed  CAS  Google Scholar 

  9. Wang, F., Gregory, C, Sample, C, Rowe, M., Liebowitz, D., Murray, R., et al. (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64, 2309–2318.

    PubMed  CAS  Google Scholar 

  10. Miltenyi, S., Mueller, M., Weichel, W., and Radbruch, A. (1990) High gradient magnetic cell separation with MACS. Cytometry 11, 231–238.

    Article  PubMed  CAS  Google Scholar 

  11. Kube, D., Vockerodt, M., Weber, O., Hell, K., Wolf, J., Haier, B., et al. (1999) Expression of Epstein-Barr Virus Nuclear Antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J. Virol. 73, 1630–1636.

    PubMed  CAS  Google Scholar 

  12. Vockerodt, M., Haier, B., Buttgereit, P., Tesch, H., Kube, D. (2001) The Epstein-Barr virus latent membrane protein 1 induces Interleukin-10 in Burkitt’s lymphoma cells but not in Hodgkin’s cells involving the p38/SAPK2 pathway. Virology, in press.

    Google Scholar 

  13. Ichijo, H., Nishida, E., Irie, K., Ten, D. P., Saitoh, M., Moriguchi, T., et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94.

    Article  PubMed  CAS  Google Scholar 

  14. Chesnut, J. D., Baytan, A. R., Russell, M., Chang, M. P., Bernard, A., Maxwell, I. H., and Hoeffler, J. P. (1996) Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J. Immunol. Methods 193, 17–27.

    Article  PubMed  CAS  Google Scholar 

  15. Martin, V. M., Siewert, C, Scharl, A., Harms, T., Heinze, R., Oehl, S., et al. (1998) Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp. Hematol. 26, 252–264.

    PubMed  CAS  Google Scholar 

  16. Falk, M. H., Tesch, H., Stein, H., Diehl, V., Jones, D. B., Fonatsch, C, and Bornkamm, G. W. (1987) Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin’s disease. Int. J. Cancer 40, 262–269.

    Article  PubMed  CAS  Google Scholar 

  17. Kube, D., Platzer, C, von Knethen, A., Straub, H., Bohlen, H., Hafner, M., and Tesch, H. (1995) Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt’s lymphoma cell lines. Cytokine 7, 1–7.

    Article  PubMed  CAS  Google Scholar 

  18. Murray, R., Young, L., Calendar, A., Gregory, C, Rowe, M., Lenoir, G, and Rickinson, A. (1988) Different patterns of EBV gene expression and of cytotoxic T-cell recognition in B cell lines infected with transforming (B95.8) or nontransforming (P3HRI) virus strain. J. Virol. 62, 894–901.

    PubMed  CAS  Google Scholar 

  19. Izumi, K. M. and Kieff, E. D. (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94, 12,592–12,597.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Kube, D., Vockerodt, M. (2001). Transient Gene Expression and MACS Enrichment. In: Wilson, J.B., May, G.H.W. (eds) Epstein-Barr Virus Protocols. Methods in Molecular Biology™, vol 174. Humana Press. https://doi.org/10.1385/1-59259-227-9:155

Download citation

  • DOI: https://doi.org/10.1385/1-59259-227-9:155

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-690-1

  • Online ISBN: 978-1-59259-227-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics